Stratec SE (LON:0RAR)

Market Cap	302.51M
Revenue (ttm)	208.48M
Net Income (ttm)	8.33M
Shares Out	n/a
EPS (ttm)	0.68
PE Ratio	36.31
Forward PE	n/a
Dividend	0.47 (1.56%)
Ex-Dividend Date	May 20, 2024

Volume	7,870
Average Volume	9,885
Open	30.90
Previous Close	30.80
Day's Range	29.60 - 31.00
52-Week Range	29.60 - 70.20
Beta	0.28
RSI	35.39
Earnings Date	Mar 27, 2025

About Stratec SE

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headqu...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 2018
• Employees: 1,480
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0RAR

Financial Performance

In 2023, Stratec SE's revenue was 261.91 million, a decrease of -4.63% compared to the previous year's 274.63 million. Earnings were 13.07 million, a decrease of -55.29%.

Financial numbers in EUR